As demonstrated on prostate cancer cells, the molecular mechanisms of resveratrol exploit the interactive effects with TNF-related apoptosis-inducing ligand (TRAIL), a protein that works as a ligand and induces the process of programed cell death. Here, TNFSF10 is linked to prostate cancer.